Highly parallel production of designer organoids by mosaic patterning of progenitors

Cell Syst. 2024 Jul 17;15(7):649-661.e9. doi: 10.1016/j.cels.2024.06.004. Epub 2024 Jul 8.

Abstract

Organoids derived from human stem cells are a promising approach for disease modeling, regenerative medicine, and fundamental research. However, organoid variability and limited control over morphological outcomes remain as challenges. One open question is the extent to which engineering control over culture conditions can guide organoids to specific compositions. Here, we extend a DNA "velcro" cell patterning approach, precisely controlling the number and ratio of human induced pluripotent stem cell-derived progenitors contributing to nephron progenitor (NP) organoids and mosaic NP/ureteric bud (UB) tip cell organoids within arrays of microwells. We demonstrate long-term control over organoid size and morphology, decoupled from geometric constraints. We then show emergent trends in organoid tissue proportions that depend on initial progenitor cell composition. These include higher nephron and stromal cell representation in mosaic NP/UB organoids vs. NP-only organoids and a "goldilocks" initial cell ratio in mosaic organoids that optimizes the formation of proximal tubule structures.

Keywords: cell patterning; high-throughput analysis; human induced pluripotent stem cells; kidney organoids; microwell array; nephron progenitors; ureteric bud.

MeSH terms

  • Cell Differentiation / physiology
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / metabolism
  • Nephrons / cytology
  • Organoids* / cytology
  • Organoids* / metabolism
  • Stem Cells / cytology